Kaya Holdings, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Craig R. Frank
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 21218 St. Andrews Blvd Boca Raton FL United States of America 33304
- IPO Date
- Aug 28, 2012
- CIK
- 0001530746
- Website
- kayaholdings.com
- Similar Companies
- Business
- Kaya Holdings, Inc. (KAYS) operates as a holding company with historical involvement in cannabis and biofuels, focusing on wellness and mental health through subsidiaries in psychedelic treatment clinics via Fifth Dimension Therapeutics, Inc. and medical cannabis operations; it produces, distributes and sells cannabis products including flower, oils, vape cartridges, cannabis-infused confections, baked goods and beverages, alongside medical and recreational cannabis and cannabidiol products, strain-specific cannabis cigarettes under the Kaya Buddies brand, strains under Kaya Farms and retail outlets under the Kaya Shack brand, primarily in the United States. Founded prior to its name change from Alternative Fuels America, Inc. in April 2015 and headquartered in Boca Raton, Florida, the company trades on the OTCQB market. In recent developments, Kaya Holdings engages Greentree Financial Group and Conduit Advisors to develop a cryptocurrency operating subsidiary and implement a Digital Assets Treasury strategy, enters agreements to convert over 90% of existing debt to equity, pursues joint ventures with top cryptocurrencies on networks like Solana, Ethereum or Polygon, and leverages connections in Grand Cayman for crypto operations as of September-October 2025.
Head-To-Head Analysis: Kaya (OTCMKTS:KAYS) vs. RealReal (NASDAQ:REAL)
Financial Analysis: Kaya (OTCMKTS:KAYS) versus Spectrum Brands (NYSE:SPB)
Contrasting Kaya (OTCMKTS:KAYS) and Pigeon (OTCMKTS:PGENY)
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
Kaya Holdings, Inc. Releases Update on Development of Cryptocurrency Subsidiary and Digital Assets Treasury
Kaya Holdings, Inc. Engages Greentree Financial Group and Conduit Advisors to Assist with Development of Cryptocurrency Subsidiary and Implementation of Digital Assets Treasury Strategy
Kaya Holdings, Inc. (OTCQB:KAYS): The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization Program
Kaya Holdings, Inc. and the Sacred Mushroom(TM) Psilocybin Treatment Facility Announce Inaugural Open House and New Series of Low-Dose Psilocybin Sessions
The Sacred Mushroom(TM) Psilocybin Center Operated by Kaya Holdings, Inc. (OTCQB:KAYS) Releases First E-Book
Kaya Holdings, Inc. (OTCQB:KAYS) Criticizes FDA Rejection of MDMA Therapy for PTSD, Proposes Psilocybin as Alternative Treatment
Kaya Holdings, Inc. Announces Grand Opening of The Sacred Mushroom, Oregon's Premier Psilocybin Center
Kaya Holdings, Inc. "The Sacred Mushroom" Psilocybin Treatment Center Begins Accepting Appointments
Kaya Holdings Awarded Psilocybin Service Center License, Launches The Sacred Mushroom Psychedelic Treatment Facility
Investor Ideas Potcasts: Interview with Kaya Holdings on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health
Kaya Holdings (OTCQB:KAYS) Unveils "The Scared Mushroom(TM)", the First U.S.-Based Psilocybin Center to be Operated by a U.S. Public Company
Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game
Kaya Holdings (OTCQB:KAYS) Closes Additional Round of Non-Dilutive Bridge Financing Targeted to Complete The Sacred Mushroom(TM) Psilocybin Treatment Center
Kaya Holdings (OTCQB:KAYS) Secures Site for The Sacred Mushroom(TM) Planned Psilocybin Treatment Center
Kaya Holdings Boosts Operations In Greece With 50% Acquisition Of Epidaurus Medical Cannabis Project
Cannabis Company Kaya Holdings, Inc. Sunstone Settlement Effective: Share Return Reduces Stock Float by 6.4%, Release of Lien Allows KAYS to Sell Warehouse Property for Cash Influx of up to $0.10 per Share